TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1.40nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1.70nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 1.70nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 2nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
Affinity DataIC50: 2.30nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
Affinity DataIC50: 2.40nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
Affinity DataIC50: 2.70nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
Affinity DataIC50: 2.90nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Rattus norvegicus (rat))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 2.90nMAssay Description:Quantification of 5-HT uptake was performed using synaptosomes isolated in a 0.32M sucrose buffer from a male Wistar rat cortex. The uptake of radiol...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 3nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 3nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 3nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 3nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 3nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
Affinity DataIC50: 3.60nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 4nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 4nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetNeuroepithelial cell-transforming gene 1 protein(Homo sapiens)
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 4nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 4nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetNeuroepithelial cell-transforming gene 1 protein(Homo sapiens)
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 4nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 5nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 5nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
Affinity DataIC50: 5.10nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
TargetNeuroepithelial cell-transforming gene 1 protein(Homo sapiens)
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6nMAssay Description:Inhibition of human norepinephrine reuptake transporter was assayed using the recombinant human norepinephrine transporter expressed in either HEK293...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6nMAssay Description:Quantification of dopamine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat striatum. The uptake of...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6nMAssay Description:Inhibition of human dopamine reuptake transporter was assayed using the recombinant human dopamine transporter expressed in either CHO-K1 or HEK293 c...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6nMAssay Description:Inhibition of human serotonin reuptake transporter was assayed using the recombinant human serotonin transporter expressed in HEK-293 cells. HEK-293 ...More data for this Ligand-Target Pair
Affinity DataIC50: 6nMAssay Description:Quantification of norepinephrine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat hypothalamus. The...More data for this Ligand-Target Pair
TargetSodium-dependent dopamine transporter(Rattus norvegicus (rat))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6.10nMAssay Description:Quantification of dopamine uptake was performed using synaptosomes isolated in a 0.32 M sucrose buffer from a male Wistar rat striatum. The uptake of...More data for this Ligand-Target Pair
TargetSodium-dependent serotonin transporter(Rattus norvegicus (rat))
SUNOVION PHARAMCEUTICALS INC.
US Patent
SUNOVION PHARAMCEUTICALS INC.
US Patent
Affinity DataIC50: 6.5nMAssay Description:Quantification of 5-HT uptake was performed using synaptosomes isolated in a 0.32M sucrose buffer from a male Wistar rat cortex. The uptake of radiol...More data for this Ligand-Target Pair